BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24425106)

  • 1. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis.
    Ping W; Sun W; Zu Y; Chen W; Fu X
    Tumour Biol; 2014 May; 35(5):4401-9. PubMed ID: 24425106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk.
    Sun G; Hu W; Lu Y; Wang Y
    Pathol Oncol Res; 2013 Oct; 19(4):685-93. PubMed ID: 23658132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between hypoxia inducible factor-1α and esophageal squamous cell carcinoma: a meta analysis].
    Jing S; Wang J; Liu Q; Cheng Y; Yang C; Wang Y; Cao F; Wen B; Jiao W; Guo Y
    Zhonghua Bing Li Xue Za Zhi; 2014 Sep; 43(9):593-9. PubMed ID: 25471499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.
    Zhou J; Huang S; Wang L; Yuan X; Dong Q; Zhang D; Wang X
    World J Surg Oncol; 2017 May; 15(1):104. PubMed ID: 28521842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.
    Zhang L; Ye SB; Li ZL; Ma G; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
    Int J Clin Exp Pathol; 2014; 7(7):3887-97. PubMed ID: 25120765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
    Zhao X; Tang YP; Wang CY; Wu JX; Ye F
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma.
    Shao N; Han Y; Song L; Song W
    J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
    Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
    Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
    Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
    Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis.
    Luo D; Ren H; Zhang W; Xian H; Lian K; Liu H
    J Orthop Surg Res; 2019 Feb; 14(1):56. PubMed ID: 30782196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis.
    Ding ZN; Dong ZR; Chen ZQ; Yang YF; Yan LJ; Li HC; Liu KX; Yao CY; Yan YC; Yang CC; Li T
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1487-1496. PubMed ID: 33393670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
    Yu ZT; Zhao HF; Shang XB
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.
    Méndez-Blanco C; Fernández-Palanca P; Fondevila F; González-Gallego J; Mauriz JL
    Ther Adv Med Oncol; 2021; 13():1758835920987071. PubMed ID: 33613697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
    BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis.
    Zheng SS; Chen XH; Yin X; Zhang BH
    PLoS One; 2013; 8(6):e65753. PubMed ID: 23799043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic significance of HIF-1α, PTEN, CD44v6, and survivin for gastric cancer: a meta-analysis.
    Chen J; Li T; Liu Q; Jiao H; Yang W; Liu X; Huo Z
    PLoS One; 2014; 9(3):e91842. PubMed ID: 24647137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.
    Kurokawa T; Miyamoto M; Kato K; Cho Y; Kawarada Y; Hida Y; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
    Br J Cancer; 2003 Sep; 89(6):1042-7. PubMed ID: 12966423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of HIF-1α in digestive system malignancies: evidence from a systematic review and meta-analysis.
    Arjmand MH; Moradi A; Rahimi HR; Es-Haghi A; Akbari A; Hadipanah MR; Afshar J; Mehrad-Majd H
    Gastroenterol Hepatol Bed Bench; 2022; 15(2):108-119. PubMed ID: 35845307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.